- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research, filed a petition with the Department of Justice (DOJ) demanding that the Drug Enforcement Administration (DEA) immediately update misinformation about cannabis. The petition is being filed under the rules of the Information Quality Act (IQA, aka Data Quality Act), which requires administrative agencies to devise guidelines that ensure the “quality, objectivity, utility, and integrity of information” they distribute and to “[e]stablish administrative mechanisms allowing affected persons to seek and obtain correction of information maintained and disseminated by the agency that does not comply with the guidelines.”
Americans for Safe Access’ complaint cites 25 violations under the IQA, alleging that the DEA website currently contains inaccurate statements that do not meet informational standards required by the law. Making matters worse, the DEA continues to distribute statements about the efficacy of medical cannabis and its risks, which have been refuted by the DEA itself in the recent “Denial of Petition to Initiate Proceedings to Reschedule Marijuana,” issued August 12, 2016.
For years, the DEA has published scientifically inaccurate information about the health effects of medical cannabis, directly influencing the action —and inaction— of Congress. In ASA’s IQA petition, we are calling out the DEA’s own statements, which confirm scientific facts about medical cannabis, and analysis that has long been accepted by a majority of the scientific community.
Our request is simple: the DEA must change its public information to better comport with its own expressed views, so that Congress has access to the appropriate tools to make informed decisions about public health. Alternatively, ASA requests that the DEA simply remove the inaccurate statements or the documents in their entirety.
“We have taken this action to stop the DEA’s relentless campaign of misinformation about the health risks of medical cannabis in its tracks,” said Vickie Feeman, an attorney with the law firm Orrick, Herrington & Sutcliffe. “We are proud to represent Americans for Safe Access pro bono in this matter to protect the rights of patients throughout the country who could be harmed – and have already been harmed – by the DEA’s refusal to not only acknowledge the scientifically proven benefits of medical cannabis, but also its deliberate attempt to inflate and publicly misrepresent the facts about the potential harms of cannabis use.”
The overwhelming majority of the objective scientific studies—including studies cited by the DEA in the “Denial of Petition to Initiate Proceedings to Reschedule Marijuana” (DPR) —disprove the DEA’s statements. Because the DEA itself made statements in the DPR that directly contradict information in “The Dangers and Consequences of Marijuana Abuse” and “Drugs of Abuse,” it is undeniable that this information lacks utility and objectivity. The presentation of scientifically unfounded information alongside scientifically accurate information obscures and diminishes the utility of the accurate information and can jeopardize public health. Moreover, the disingenuous presentation of inaccurate information makes it difficult for public officials and medical providers to make informed decisions regarding the viability of medical cannabis treatment options.
This is something President Obama can correct before he leaves office. Success in correcting this information will mean politicians can no longer use the misinformation about (1) the gateway drug hypothesis (2) irreversible cognitive decline in adults; and cannabis causing (3) psychosis or (4) lung cancer to deny patients access to medical cannabis.
This petition has been filed on behalf of our members, join ASA today to be a part of of history.
- For more information on the Information Quality Act: safeaccessnow.org/what_is_the_information_quality_act
- View the petition here: safeaccessnow.org/doj_iqa
- Denial of Petition to Initiate Proceedings to Reschedule Marijuana: safeaccessnow.org/dea_denial
- DEA’s The Dangers and Consequences of Marijuana Abuse: safeaccessnow.org/dea_danger
- DEA’s Drugs of Abuse: safeaccessnow.org/dea_abuse
How can you help?
We have a petition asking President Obama to instruct the DEA to correct the information. We need you to sign and share this Change.org petition asking President Obama to instruct the DEA to correct the information before he leaves office. The ONLY way we can achieve the required 100,000 signatures is with YOUR help!